GENE ONLINE|News &
Opinion
Blog

2021-05-20| Technology

New Technique Could Challenge CRISPR by Editing Millions of DNA Sites Simultaneously

by Sahana Shankar
Share To
Gene editing has enabled us to push the limits of synthetic biology with multiple technologies such as CRISPR-Cas9, TALENs (transcription activator-like effector nucleases), and ZFNs (zinc-finger nucleases), which focus on cutting the DNA sequence at specific sites to edit it.

While these have been highly versatile and improvised for multiple applications, they are limited in scale. Using recombination and a retron library, scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School have designed a high-throughput gene editing method called Retron Library Recombineering (RLR).

RLR can edit millions of DNA sites simultaneously, where each mutation can be followed and screened with its unique barcode. This enables simultaneous and quantitative analysis of millions of experiments which can help understand the interplay of mutations at the whole genome level.

GO Prime with only $1.49 now

LATEST
AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing
2025-03-19
Edge Computing: The Next Big Thing in AI and Automation
2025-03-19
Neurosurgery Now: NVIDIA’s Holoscan AI Brings Real-Time 3D Vision to Enhance Surgical Precision at 2025 GTC
2025-03-18
NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery
2025-03-18
AstraZeneca Acquires Cell Therapy Company in $1 Billion Deal to Develop In Vivo Cancer Treatments
2025-03-18
Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient
2025-03-17
NICE Recommends New Endometriosis Treatment for NHS Patients
2025-03-14
EVENT
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
Scroll to Top